Home › Endodermal Sinus Tumor
Endodermal Sinus Tumor clinical trials recruiting in the U.S.
5 studies for Endodermal Sinus Tumor are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Molecular Epidemiology of Pediatric Germ Cell Tumors
RecruitingObservational study
All ages · All sexes · Updated Nov 13, 2026 · NCT05564026Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RecruitingPhase 3
All ages · All sexes · Updated Aug 25, 2026 · NCT03067181Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Aug 6, 2026 · NCT04715191Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RecruitingPhase 1
Ages 1 to 26 · All sexes · Updated Feb 17, 2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RecruitingPhase 1
Up to age 21 · All sexes · Updated Nov 3, 2025 · NCT06198296From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.